Sandra E. Saucier

Array ( [id] => 3610610 [patent_doc_number] => 05565317 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-15 [patent_title] => 'Perfusion and storage solution containing sodium lactobionate, sodium dihydrogenphosphate, raffinose, glutathione, allopurinol and nafamostat mesylate' [patent_app_type] => 1 [patent_app_number] => 8/347490 [patent_app_country] => US [patent_app_date] => 1994-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1569 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/565/05565317.pdf [firstpage_image] =>[orig_patent_app_number] => 347490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3811203 [patent_doc_number] => 05789147 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-04 [patent_title] => 'Method for concentrating white cells from whole blood by adding a red cell sedimentation reagent to whole anticoagulated blood' [patent_app_type] => 1 [patent_app_number] => 8/349747 [patent_app_country] => US [patent_app_date] => 1994-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 5529 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/789/05789147.pdf [firstpage_image] =>[orig_patent_app_number] => 349747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3812028 [patent_doc_number] => 05710038 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-20 [patent_title] => 'Primary cultures of normal and tumoral human ovarian epithelium' [patent_app_type] => 1 [patent_app_number] => 8/344960 [patent_app_country] => US [patent_app_date] => 1994-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 10116 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/710/05710038.pdf [firstpage_image] =>[orig_patent_app_number] => 344960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3690495 [patent_doc_number] => 05604127 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-18 [patent_title] => 'Probiotic for control of Salmonella in fowl produced by continuous culture of fecal/cecal material' [patent_app_type] => 1 [patent_app_number] => 8/345010 [patent_app_country] => US [patent_app_date] => 1994-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6086 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/604/05604127.pdf [firstpage_image] =>[orig_patent_app_number] => 345010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3665287 [patent_doc_number] => 05597800 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-28 [patent_title] => 'Treatment with lys-plasminogen of reperfusion injury and brain edema caused by ischemia' [patent_app_type] => 1 [patent_app_number] => 8/345468 [patent_app_country] => US [patent_app_date] => 1994-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 4791 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/597/05597800.pdf [firstpage_image] =>[orig_patent_app_number] => 345468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3646647 [patent_doc_number] => 05629200 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-13 [patent_title] => 'Production of optically active 2-amino-1-phenylethanol derivatives by asymetrical assimilation' [patent_app_type] => 1 [patent_app_number] => 8/343952 [patent_app_country] => US [patent_app_date] => 1994-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41209 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 1193 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/629/05629200.pdf [firstpage_image] =>[orig_patent_app_number] => 343952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3685997 [patent_doc_number] => 05691132 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-25 [patent_title] => 'Method for inactivating pathogens in red cell compositions using quinacrine mustard' [patent_app_type] => 1 [patent_app_number] => 8/338040 [patent_app_country] => US [patent_app_date] => 1994-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 20745 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/691/05691132.pdf [firstpage_image] =>[orig_patent_app_number] => 338040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3619924 [patent_doc_number] => 05593823 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-14 [patent_title] => 'Method for inactivating pathogens in blood using photoactivation of 4\'-primary amino-substituted psoralens' [patent_app_type] => 1 [patent_app_number] => 8/337987 [patent_app_country] => US [patent_app_date] => 1994-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 48 [patent_no_of_words] => 35375 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 247 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/593/05593823.pdf [firstpage_image] =>[orig_patent_app_number] => 337987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3795371 [patent_doc_number] => 05827641 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-27 [patent_title] => 'In vitro cornea equivalent model' [patent_app_type] => 1 [patent_app_number] => 8/337830 [patent_app_country] => US [patent_app_date] => 1994-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 36 [patent_no_of_words] => 7596 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/827/05827641.pdf [firstpage_image] =>[orig_patent_app_number] => 337830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3407287 [patent_doc_number] => 05460797 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-10-24 [patent_title] => 'Method for fixing tissues and cells for analysis using oxazolidine compounds' [patent_app_type] => 1 [patent_app_number] => 8/333875 [patent_app_country] => US [patent_app_date] => 1994-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 6261 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/460/05460797.pdf [firstpage_image] =>[orig_patent_app_number] => 333875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3503867 [patent_doc_number] => 05514536 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-07 [patent_title] => 'Solutions for tissue preservation and bloodless surgery and methods using same' [patent_app_type] => 1 [patent_app_number] => 8/328020 [patent_app_country] => US [patent_app_date] => 1994-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 14183 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 329 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/514/05514536.pdf [firstpage_image] =>[orig_patent_app_number] => 328020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3537736 [patent_doc_number] => 05494821 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-02-27 [patent_title] => 'Process for separating optically active 1-hydroxy-cyclopentane methanol derivatives using lipase from candida or pseudomonas' [patent_app_type] => 1 [patent_app_number] => 8/322725 [patent_app_country] => US [patent_app_date] => 1994-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4805 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 222 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/494/05494821.pdf [firstpage_image] =>[orig_patent_app_number] => 322725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3767100 [patent_doc_number] => 05773264 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-30 [patent_title] => 'Process for the production of 17 .alpha.-hydroxy-3-methoxy-8,14-seco-1,3,5(10),9(11)estratetraen-14-one by reduction of the corresponding 17-one compound' [patent_app_type] => 1 [patent_app_number] => 8/313063 [patent_app_country] => US [patent_app_date] => 1994-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 799 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/773/05773264.pdf [firstpage_image] =>[orig_patent_app_number] => 313063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3645556 [patent_doc_number] => 05637500 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-10 [patent_title] => 'Process for preparing optically active alpha-hydroxyalkene derivatives' [patent_app_type] => 1 [patent_app_number] => 8/311885 [patent_app_country] => US [patent_app_date] => 1994-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1979 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/637/05637500.pdf [firstpage_image] =>[orig_patent_app_number] => 311885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3579945 [patent_doc_number] => 05498519 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-03-12 [patent_title] => 'Hypothermic preservation of mammalian hearts by blocking the Na.sup.+ /K.sup.+ /Cl.sup.- co-transporter using the co-transporter blocker, furosemide' [patent_app_type] => 1 [patent_app_number] => 8/310371 [patent_app_country] => US [patent_app_date] => 1994-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 2675 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/498/05498519.pdf [firstpage_image] =>[orig_patent_app_number] => 310371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3492526 [patent_doc_number] => 05561057 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-01 [patent_title] => 'Resolution of (RS)-ibuprofen by Candida antarctica catalyzed esterification with long chain alcohols while removing water' [patent_app_type] => 1 [patent_app_number] => 8/309434 [patent_app_country] => US [patent_app_date] => 1994-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 1661 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/561/05561057.pdf [firstpage_image] =>[orig_patent_app_number] => 309434 [rel_patent_id] =>[rel_patent_doc_number] =>)